[Comments on five clinical trials concerning radiotherapy-induced mucositis in patients with head and neck neoplasms].
Noël
G
G
Service des tumeurs,   groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75651 Paris, France.
Mazeron
J J
JJ
D004999:Amifostine / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D005973:Glutamine / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D010865:Pilot Projects; D011446:Prospective Studies; D011832:Radiation Injuries / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D013280:Stomatitis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D013392:Sucralfate / Q000627:therapeutic use*; D014987:Xerostomia / Q000209:etiology / Q000517:prevention & control
D011837:Radiation-Protective Agents; D005973:Glutamine; D013392:Sucralfate; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D004999:Amifostine